Altium Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $2.17M | Buy |
38,852
+4,228
| +12% | +$236K | 0.16% | 81 |
|
|
2022
Q1 | $1.92M | Buy |
34,624
+4,786
| +16% | +$266K | 0.12% | 95 |
|
|
2021
Q4 | $1.67M | Buy |
29,838
+3,854
| +15% | +$216K | 0.11% | 103 |
|
|
2021
Q3 | $1.25M | Buy |
25,984
+398
| +2% | +$19.1K | 0.09% | 109 |
|
|
2021
Q2 | $1.07M | Buy |
25,586
+5,194
| +25% | +$218K | 0.08% | 121 |
|
|
2021
Q1 | $687K | Buy |
20,392
+8,340
| +69% | +$281K | 0.06% | 166 |
|
|
2020
Q4 | $421K | Sell |
12,052
-3,882
| -24% | -$136K | 0.04% | 227 |
|
|
2020
Q3 | $553K | Buy |
15,934
+914
| +6% | +$31.7K | 0.06% | 148 |
|
|
2020
Q2 | $492K | Buy |
15,020
+2,886
| +24% | +$94.5K | 0.06% | 163 |
|
|
2020
Q1 | $365K | Buy |
+12,134
| New | +$365K | 0.05% | 179 |
|